CHLOROTOXIN VARIANTS, CONJUGATES AND METHODS FOR THEIR USE
    72.
    发明公开
    CHLOROTOXIN VARIANTS, CONJUGATES AND METHODS FOR THEIR USE 审中-公开
    氯诺昔林变体,缀合物及其使用方法

    公开(公告)号:EP3165533A1

    公开(公告)日:2017-05-10

    申请号:EP16189999.2

    申请日:2011-02-04

    发明人: OLSON, James M.

    摘要: Chlorotoxin variants, chlorotoxin variant conjugates, compositions that include the chlorotoxin variants or conjugates, and methods for using the chlorotoxin variants, conjugates, and compositions. In particular, conjugates comprising a chlorotoxin variant where lysine K15 and/or lysine K23 are substituted by other amino acids, coupled to a fluorescent label.

    摘要翻译: 氯毒素变体,氯毒素变体缀合物,包含氯毒素变体或缀合物的组合物,以及使用氯毒素变体,缀合物和组合物的方法。 特别地,包含氯代毒素变体的缀合物,其中赖氨酸K15和/或赖氨酸K23被其他氨基酸取代,与荧光标记偶联。

    METHODS AND MATERIALS FOR CANINE BREED IDENTIFICATION
    73.
    发明公开
    METHODS AND MATERIALS FOR CANINE BREED IDENTIFICATION 有权
    VERFAHREN UND MATERIALIEN ZUR鉴定DER HUNDEART

    公开(公告)号:EP2944957A1

    公开(公告)日:2015-11-18

    申请号:EP15163430.0

    申请日:2004-12-15

    摘要: In one aspect, the invention provides methods for determining the contributions of canid populations to a canid genome. The methods comprise the steps of: (a) obtaining the identity of one or both alleles in a test canid genome for each of a set of markers; and (b) determining the contributions of canid populations to the test canid genome by comparing the alleles in the test canid genome to a database comprising canid population profiles, wherein each canid population profile comprises genotype information for the set of markers in the canid populations.

    摘要翻译: 一方面,本发明提供了确定犬种群对犬科基因组的贡献的方法。 所述方法包括以下步骤:(a)在一组标记物中获得测试犬基因组中一个或两个等位基因的同一性; 并且(b)通过将测试犬基因组中的等位基因与包含犬种群概况的数据库进行比较来确定犬种群对测试犬基因组的贡献,其中每个犬种群体谱包括在犬种群中的该组标记的基因型信息。

    COMPOSITIONS AND METHODS FOR ENHANCED GENERATION OF HEMATOPOIETIC STEM/PROGENITOR CELLS
    78.
    发明公开
    COMPOSITIONS AND METHODS FOR ENHANCED GENERATION OF HEMATOPOIETIC STEM/PROGENITOR CELLS 审中-公开
    组合物和方法的造血干/祖细胞的增加的生产

    公开(公告)号:EP2788476A1

    公开(公告)日:2014-10-15

    申请号:EP12806795.6

    申请日:2012-12-07

    IPC分类号: C12N5/0789 A61K35/12

    摘要: The present invention relates to methods, kits and compositions for expansion of hematopoietic stem/progenitor cells and providing hematopoietic function to human patients in need thereof. In one aspect, it relates to kits and compositions comprising a Notch agonist and an aryl hydrocarbon receptor antagonist. Also provided herein are methods for expanding the hematopoietic stem/progenitor cells using kits and compositions comprising a Notch agonist and an aryl hydrocarbon receptor antagonist. The hematopoietic stem/progenitor cells expanded using the disclosed kits, compositions and methods include human umbilical cord blood stem/progenitor cells, placental cord blood stem/progenitor cells and peripheral blood stem cells. The present invention also relates to administering hematopoietic stem/progenitor cells expanded using a combination of a Notch agonist and an aryl hydrocarbon receptor antagonist to a patient for short-term and/or long-term in vivo repopulation benefits.

    摘要翻译: 本发明涉及一种方法,试剂盒和组合物的造血干/祖细胞和造血功能提供对人类患者需要其的膨胀。 在一个方面,它涉及试剂盒和组合物,包含一陷波激动剂芳香烃受体拮抗剂和。 所以提供了用于使用试剂盒扩大的造血干/祖细胞和组合物,其包括的Notch激动剂芳香烃受体拮抗剂和方法。 使用盘扩大了的造血干/祖细胞的试剂盒游离缺失,组合物和方法包括人脐血干/祖细胞,胎盘脐带血干细胞/祖细胞和外周血干细胞。 因此,本发明涉及管理使用的Notch激动剂和芳香烃受体拮抗剂的组合,以在体内再增殖好处短期和/或长期的患者扩增的造血干/祖细胞。

    COMPOSITIONS, METHODS AND USES FOR RADIOPROTECTANTS
    79.
    发明公开
    COMPOSITIONS, METHODS AND USES FOR RADIOPROTECTANTS 审中-公开
    组合物,方法和用途辐射保护手段

    公开(公告)号:EP2683398A1

    公开(公告)日:2014-01-15

    申请号:EP12757360.8

    申请日:2012-03-09

    IPC分类号: A61K38/55 A61P35/00

    摘要: Embodiments described herein relate to compositions, methods and uses for alpha-1 antitrypsin (AAT) or derivatives or analogs or peptides or mutants thereof for treating a subject exposed to radiation. In certain embodiments, AAT or derivatives thereof or analogs thereof can be used to modulate adverse effects of radiation therapy on subjects undergoing treatment for cancer. In other embodiments, compositions disclosed herein can be used for treating a subject having been exposed to non-therapeutic or accidental radiation. Some embodiments reported herein concern compositions and methods for enhancing radiotherapy. Certain embodiments relate to methods and compositions for preventing or reducing radiation exposure-induced cellular damage in a subject.

    Use of oxygen antagonists for the therapeutic treatment of mammals
    80.
    发明公开
    Use of oxygen antagonists for the therapeutic treatment of mammals 审中-公开
    使用氧拮抗剂用于对哺乳动物进行治疗性处置

    公开(公告)号:EP2363022A3

    公开(公告)日:2011-12-21

    申请号:EP11157706.0

    申请日:2004-10-22

    IPC分类号: A01N1/02

    摘要: There is provided the use of oxygen antagonists for inducing stasis in cells, tissues and/or organs in vivo or in an organism overall. It includes methods and apparatuses for achieving stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia and cancer is provided.